- Home
- VINP vs EIKN Comparison
VINP vs EIKN Comparison
Compare VINP & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VINP | EIKN |
|---|---|---|
| Founded | 2009 | 2019 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 638.8M | 631.0M |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | VINP | EIKN |
|---|---|---|
| Price | $9.60 | $11.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $14.00 | ★ $25.60 |
| AVG Volume (30 Days) | 34.0K | ★ 455.4K |
| Earning Date | 05-11-2026 | 03-30-2026 |
| Dividend Yield | ★ 5.72% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.07 | N/A |
| Revenue Next Year | $12.74 | N/A |
| P/E Ratio | $24.41 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.19 | $7.90 |
| 52 Week High | $13.61 | $16.50 |
Technical Indicators
Market Signals| Indicator | VINP | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 47.87 | 55.66 |
| Support Level | $9.43 | $8.62 |
| Resistance Level | $10.26 | $12.16 |
| Average True Range (ATR) | 0.29 | 1.17 |
| MACD | 0.00 | 0.16 |
| Stochastic Oscillator | 39.58 | 43.54 |
Price Performance
Historical ComparisonAbout VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.